文献速递肝病

肝脏干扰素调节因子6通过转录抑制过氧化物酶体增殖物激活受体γ减轻小鼠肝脏脂肪变性和代谢紊乱

Hepatic Interferon Regulatory Factor 6 Alleviates Liver Steatosis and Metabolic Disorder by Transcriptionally Suppressing Peroxisome Proliferator-Activated Receptor γ in Mice.
PubMed 文献 · Hepatology · 2019-04-22

研究整合公共基因组数据与啮齿类非酒精性脂肪性肝病样本,发现高脂饮食诱导的脂肪肝中干扰素调节因子6(IRF6)显著下调。肝细胞特异性敲除Irf6加重高脂饮食诱导的肝脏脂肪变性,而过表达Irf6的转基因小鼠脂肪变性和代谢紊乱减轻。机制上IRF6直接结合PPARγ启动子抑制其转录。

要点

  • 高脂饮食诱导的脂肪肝中IRF6因启动子高甲基化而下调。
  • 肝细胞特异性敲除Irf6加重高脂饮食诱导的肝脏脂肪变性。
  • 肝细胞过表达Irf6减轻高脂饮食诱导的脂肪变性和代谢紊乱。

核心结论

  • 代谢刺激暴露后Irf6因启动子高甲基化而下调,无法抑制Pparγ及其靶基因,驱动脂质代谢异常。

研究设计与样本

  • 研究整合Gene Expression Omnibus(GEO)公共基因组数据与啮齿类非酒精性脂肪性肝病样本,并结合肝细胞特异性Irf6敲除和过表达转基因小鼠模型进行体内外机制研究。

主要发现

  • 高脂饮食诱导的脂肪肝中IRF6显著下调。
  • 肝细胞特异性Irf6敲除小鼠在高脂饮食下肝脏脂肪变性加重。
  • 肝细胞特异性过表达Irf6转基因小鼠(IRF6-HTG)在高脂饮食下脂肪变性和代谢紊乱减轻。
  • 体外机制研究显示肝细胞IRF6直接结合PPARγ基因启动子,在生理条件下终止Pparγ及其靶基因(如调控脂肪生成和脂肪酸摄取的基因)的转录。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Nonalcoholic fatty liver disease (NAFLD) has become a worldwide epidemic. A large and growing unmet therapeutic need has inspired numerous studies in the field. Integrating the published genomic data available in the Gene Expression Omnibus (GEO) with NAFLD samples from rodents, we discovered that interferon regulatory factor 6 (IRF6) is significantly downregulated in high-fat diet (HFD)-induced fatty liver. In the current study, we identified IRF6 in hepatocytes as a protective factor in liver steatosis (LS). During HFD challenge, hepatic Irf6 was suppressed by promoter hypermethylation. Severity of HFD-induced LS was exacerbated in hepatocyte-specific Irf6 knockout mice, whereas hepatocyte-specific transgenic mice overexpressing Irf6 (IRF6-HTG) exhibited alleviated steatosis and metabolic disorder in response to HFD feeding. Mechanistic studies in vitro demonstrated that hepatocyte IRF6 directly binds to the promoter of the peroxisome proliferator-activated receptor γ (PPARγ) gene and subsequently halts the transcription of Pparγ and its target genes (e.g., genes that regulate lipogenesis and lipid acid uptake) under physiological conditions. Conclusion: Irf6 is downregulated by promoter hypermethylation upon metabolic stimulus exposure, which fail to inhibit Pparγ and its targets, driving abnormalities of lipid metabolism.

来源:Hepatology,查看原文。版权归原作者所有。

引用

  1. Tong J, Han CJ, Zhang JZ, et al. Hepatic Interferon Regulatory Factor 6 Alleviates Liver Steatosis and Metabolic Disorder by Transcriptionally Suppressing Peroxisome Proliferator-Activated Receptor γ in Mice. Hepatology. 2019. PMID: 30748020. doi:10.1002/hep.30559

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。